The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?

@article{Weeks2015ThePA,
  title={The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?},
  author={Andrew D. Weeks},
  journal={BJOG: An International Journal of Obstetrics \& Gynaecology},
  year={2015},
  volume={122},
  pages={202 - 212}
}
  • A. Weeks
  • Published 1 January 2015
  • Medicine
  • BJOG: An International Journal of Obstetrics & Gynaecology
Postpartum haemorrhage (PPH) remains a major cause of maternal deaths worldwide, and is estimated to cause the death of a woman every 10 minutes. This review presents the latest clinical advice, including new evidence on controlled cord traction, misoprostol, and oxytocin. The controversy around the diagnosis of PPH, the limitations of universal prophylaxis, and novel ways to provide obstetric first aid are also presented. It ends with a call to develop high‐quality front‐line obstetric… Expand
Re: The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?
  • S. Matsubara
  • Medicine
  • BJOG : an international journal of obstetrics and gynaecology
  • 2015
Sir, Weeks comprehensively described the present treatment trend of postpartum haemorrhage, concerning which Minicommentaries or Exchanges have been published one after another, indicatingExpand
Frequency of retained placenta in patients presenting with postpartum haemorrhage after active management of third stage of labour
TLDR
Genital tract trauma, uterine atony, retained placenta are the most persistent causes of PPH and after delivery retained placental tissue (RPT) occurs in almost 1% of patients. Expand
Chapter 12: Improving Blood Transfusion Services
TLDR
There are a number of barriers to the provision of transfusion services, especially in low- and middle-income settings where the need is the greatest, including unavailability of blood, unsafe blood, poor uptake of labour and delivery care, difficulties getting blood to transfusing facilities, and poor documentation of patient information. Expand
Aetiology and treatment of severe postpartum haemorrhage.
TLDR
An improved diagnosis of the causes of PPH especially retained placenta, together with an early recognition and treatment of coagulopathy, seem to be important in reducing severe PPH in an aim to minimize associated maternal morbidity. Expand
The incidence of postpartum hemorrhage after spontaneous and induced vaginal delivery versus elective and emergency caesarian section
TLDR
The results indicated that the identified risk factors of PPH are essential to increase effective care and eventually increased the maternal survival. Expand
Postpartum Hysterectomy a Case Report of a Saving Life Surgery
TLDR
Postpartum hemorrhage is the most cause of maternal mortality all over the world important and the latest professional apt to perform surgical procedures, such as B-Lynch surgery and the peripartum hysterectomy are needed. Expand
Improving blood transfusion services.
  • T. Tancred, I. Bates
  • Medicine
  • Best practice & research. Clinical obstetrics & gynaecology
  • 2019
TLDR
There are a number of barriers to the provision of transfusion services, especially in low- and middle-income settings where the need is the greatest, including unavailability of blood, unsafe blood, poor uptake of labour and delivery care, difficulties getting blood to transfusing facilities and poor documentation of patient information. Expand
To study the association of high risk factors and the postpartum hemorrhage at Tertiary Care Centre of Indore
TLDR
It is hoped that this review paper increases the awareness of the various tamponade balloons and contributes to an evidencebased appraisal of its place in the management of PPH. Expand
Carbetocin versus oxytocin for the prevention of postpartum haemorrhage during caesarean section-A study of 100 cases in Combined Military Hospital, Momenshahi
TLDR
The main objective of this study is to find most crucial and effective drug of PPH prevention by comparing effectiveness of carbetocin vs. oxytocin. Expand
Re: The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go next?
  • U. Esen
  • Medicine
  • BJOG : an international journal of obstetrics and gynaecology
  • 2015
TLDR
It is observed that in a cohort of women with a low transverse vaginal septum, there was no hymen development anatomically, which may indicate a point in the embryological development of the hymen. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 77 REFERENCES
Postpartum haemorrhage
TLDR
While most women with postpartum blood loss less than 1000mL suffer no significant morbidity, the percentage of women who suffer a major PPH at the Women’s is comparable with local and international figures of 1-2%. Expand
Prevention and Management of Postpartum Haemorrhage
TLDR
These guidelines provide guidelines to help clinicians prevent and manage excessive bleeding postpartum and establish practices to facilitate the identification of women who may be at particularly high risk of PPH. Expand
Carbetocin for preventing postpartum haemorrhage.
BACKGROUND Postpartum haemorrhage (PPH) is one of the major contributors to maternal mortality and morbidity worldwide. Active management of the third stage of labour has been proven to be effectiveExpand
Postpartum misoprostol for preventing maternal mortality and morbidity.
TLDR
To review maternal deaths and severe morbidity in all randomised trials of misoprostol for prevention or treatment of PPH, a large number of women will be needed to obtain robust estimates of maternal mortality, and cluster- and quasi-randomised trials are planned. Expand
Tranexamic acid for preventing postpartum haemorrhage.
TLDR
Tranexamic acid decreases postpartum blood loss after vaginal birth and after caesarean section based on two RCTs of unclear quality and further investigations are needed on efficacy and safety of this regimen for preventing PPH. Expand
Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe
TLDR
A survey of policies for management of the third stage of labour and immediate management of postpartum haemorrhage following vaginal birth in Europe and a review of attitudes, trial, and early warning system projects. Expand
Prevention and treatment of postpartum hemorrhage in low‐resource settings
  • A. Lalonde
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2012
TLDR
The following guideline provides a comprehensive document regarding best practice for the prevention and treatment of postpartum hemorrhage (PPH) in low-resource settings. Expand
Prostaglandins for preventing postpartum haemorrhage.
TLDR
Misoprostol orally or sublingually at a dose of 600 mcg shows promising results when compared to placebo in reducing blood loss after delivery and is preferable to conventional injectable uterotonics as part of the management of the third stage of labour especially for low-risk women. Expand
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour
TLDR
A multicentre, double-blind, randomised controlled trial to determine whether oral misoprostol is as effective as oxytocin during the third stage of labour and the use of additional uterotonics without an unacceptable level of side-effects. Expand
Active management of the third stage of labour.
TLDR
The purpose of the investigation described here is to present the results of an active policy of third-stage management in hospital deliveries conducted principally by midwives, pupil midwife, and medical students and to assess the suitability of such a policy for use in domiciliary as well as in hospital practice. Expand
...
1
2
3
4
5
...